Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine

被引:27
作者
Li, Ruixiao [1 ,2 ]
Li, Qi [1 ,2 ,3 ]
Ji, Qing [1 ,2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, 528 Zhangheng Rd, Shanghai 201203, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Canc Inst, 528 Zhangheng Rd, Shanghai 201203, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor; Targeted therapy; Western medicine; Traditional Chinese medicine; Ingredient; BREAST-CANCER CELLS; FOCAL ADHESION KINASE; BETULINIC ACID; HEPATOCELLULAR-CARCINOMA; DRUG DISCOVERY; NETWORK PHARMACOLOGY; RAF/MEK/ERK PATHWAY; SIGNALING PATHWAYS; LUNG METASTASIS; RECEPTOR-ALPHA;
D O I
10.1016/j.biopha.2019.109624
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Malignant tumor has been always endangering human health, and its morbidity and mortality have been increasing year by year. At present, the main clinical treatment of malignant tumors is surgery, radiotherapy and chemotherapy, but it is difficult to achieve satisfactory prognosis. In recent years, targeted therapy for various tumors has been more and more popular. Molecular targeted drugs are mainly targeted at key targets in the development of malignant tumors. Some molecular targeted drugs have shown good results in the corresponding tumor treatment. More and more molecular targeted drugs have been developed and produced due to the well understanding of the molecular targets and involved pathways of tumorigenesis and development. In this review, we will summarize the direct targets of western medicine targeted drugs and traditional Chinese medicine monomers, as well the study methods about molecular targets. The purpose of this review is to seek the best ways to find out the targets and pathways of the active ingredients of traditional Chinese medicine by referring to the research methods of western medicine.
引用
收藏
页数:12
相关论文
共 131 条
[1]   Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice [J].
Aggarwal, BB ;
Shishodia, S ;
Takada, Y ;
Banerjee, S ;
Newman, RA ;
Bueso-Ramos, CE ;
Price, JE .
CLINICAL CANCER RESEARCH, 2005, 11 (20) :7490-7498
[2]  
Ando N, 2007, ONCOL REP, V18, P879
[3]  
[Anonymous], SCI STKE
[4]  
[Anonymous], SHANGHAI J TRADITION
[5]  
[Anonymous], CHONGQING MED
[6]  
[Anonymous], MOL CELLULAR PHARM
[7]  
[Anonymous], J CHINA JAPAN FRIEND
[8]  
[Anonymous], CHIN J CANC PREV TRE
[9]  
[Anonymous], WORLD CHINESE MED
[10]  
[Anonymous], ONCOTARGET